Latest Content

After a sudden collapse, a resilient cancer survivor faces a new health crisis. Through faith, PT and grit, she overcomes despair to walk again.

Dr. Sunil Dutta discusses treatment approaches and managing side effects in esophageal cancer, including nutrition and patient support strategies.

The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer, highlighting ongoing need for better first-line treatments.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast cancer survivors.

A tribute to Erin Cummings, a pillar of the Hodgkin lymphome survivor community who mentored others with the wisdom and grace of a real-life Mr. Miyagi.

FDA grants Priority Review for Padcev plus Keytruda in muscle-invasive bladder cancer, showing improved survival and reduced recurrence risk.

A man with small cell lung cancer describes carboplatin-related hearing loss, fatigue and daily challenges that have reshaped his life, while holding onto perspective and resilience.

At NCCN 2026, Anjali Albanese discussed how young adults with cancer face grief, isolation and loss of control that impact their emotional well-being.

Dr. Michael K. Wong explains why immunotherapy makes skin hypersensitive, and how to spot red-flag reactions during melanoma care.

Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion.

Dr. Charles Peyton discusses the growing number of bladder cancer therapies and emphasizes the importance of personalized care and patient education.

Dr. Thomas Flaig highlights the importance of multidisciplinary care and clinical trials in guiding personalized bladder cancer treatment decisions.